Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

NOTICIAS


16 junio 2016

Studies show promising results for Q-Collar head collision protection device

Neuro News

Two new studies involving high school football and hockey players have indicated wearing a specifically-designed compression collar around the neck may prevent or reduce the effects of head collisions in sports. The neck device, called a Q-Collar, is designed to press gently on the jugular vein to slow blood outflow increasing the brain’s blood volume. The resulting effect of the increased blood volume should help the brain fit tighter within the skull cavity, reducing the energy absorbed by the brain during collisions.

15 junio 2016

Pulse frequency is “vital parameter” for successful spinal cord stimulation therapy

Neuro News

The importance of pulse frequency as a parameter in neurostimulation is well-known. Data published in Neuromodulation: Technology at the Neural Interface offer an analysis of the effects of pulse frequency alteration on stimulation thresholds, paraesthesia site coverage and patient sensation and satisfaction associated with spinal cord stimulation.

15 junio 2016

There is a “place” for MR imaging in acute stroke

Neuro News

Magnetic resonance (MR) imaging may have advantages over other imaging modalities in later time windows when it comes to selecting patients for endovascular treatment of acute ischaemic stroke. That is according to Gregory Albers (Stanford University Medical Center, Stanford, USA). He made this assessment during a presentation at the International Stroke Conference (ISC; 17–19 February, Los Angeles, USA).

15 junio 2016

Terumo acquires Sequent Medical

Neuro News

Terumo Corporation has announced that it has entered into an agreement to purchase Sequent Medical, known for its WEB aneurysm embolisation device.

15 junio 2016

Concussion outcome predicted with diffusion tensor imaging

Neuro News

Using an advanced imaging technique, researchers at Albert Einstein College of Medicine and Montefiore Health System (Montefiore, USA) were able to predict which patients who had recently suffered concussions were likely to fully recover.

06 junio 2016

Windpact launches Crash Cloud helmet technology

Neuro News

Windpact has launched the Crash Cloud system, with the aim of reducing rates of concussion. The Crash Cloud system is made up of three elements: Wind Springs, Impact Vents and Refresh Vents.

01 junio 2016

European Union agrees new rules for approving medical devices and in vitro diagnostic medical devices

Neuro News

The Netherlands presidency of the European Council and representatives of the European Parliament have reached a political agreement on two draft regulations for medical devices. The new regulations are aimed at ensuring that medical devices and in vitro diagnostic medical devices are safe while allowing patients to benefit of innovative health care solutions in a timely manner. However, the agreement is subject to the approval by the Council’s Permanent Representatives Committee and of the Parliament’s ENVI committee.

01 junio 2016

Paraesthesia may increase attention to pain, study finds

Neuro News

A study recently published in the journal Neuromodulation has concluded that using spinal cord stimulation devices, paraesthesia are not necessary for pain relief and may actually increase attention to pain.

25 mayo 2016

CE mark granted to Mainstay Medical for ReActiv8

Neuro News

Mainstay Medical International has received CE mark approval for ReActiv8, its proprietary implantable neurostimulation system designed to treat disabling chronic low back pain.

12 mayo 2016

Thousandth patient enrolled in Stryker’s Trevo Retriever Registry

Neuro News

Data from the first 500 patients was presented at the European Stroke Organization Conference (ESOC) in Barcelona, Spain, by Antonin Krajina (Hradec Kralove, Czech Republic). The data showed that 9 out of 10 patients had complete or near complete removal of the clot and over half were functionally independent. In a subset of these 500 patients, over 58% were functionally independent at 90 days. This closely matches the population of the interventional arm in a meta-analysis of randomised clinical trials for ischaemic stroke, according to a company release.

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.